Alpha Profiles · Company Profile

Pulmonx Corp

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/pulmonx-corp

Entity: Public listing published
Primary listing: NASDAQ: LUNG
Verification: Partially verified
Last reviewed: 2026-10-14T04:46:55.147613+00:00

Overview

Alpha's canonical identity and public leadership record for Pulmonx Corp.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

David Lehman

General Counsel

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-016105Apr 22, 2026

Derrick Sung

Chief Operating Officer and Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-016105Apr 22, 2026

Geoffrey Beran Rose

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-016105Apr 22, 2026

Glendon E. French

Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-016105Apr 22, 2026

Srikanth Radhakrishnan

Chief Science and Technology Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-016105Apr 22, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 14, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.